Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03752827 · ClinicalTrials.gov registry record · NA
Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
A NA study of Rotator Cuff Tear and Rotator Cuff Tendinitis, sponsored by InGeneron.
- Active
- Registry status
- NA
- Development phase
- 168
- Enrollment target
- 14
- Study locations
NCT03752827 is a NA study of Rotator Cuff Tear and Rotator Cuff Tendinitis that is active but no longer recruiting, run by InGeneron. The registered enrollment target is 168 participants, above the 78-participant average among 11 other Rotator Cuff Tear trials with a reported enrollment target (115% higher). The trial reports 14 study locations across 9 states.
The verdict
NCT03752827, a NA study of Rotator Cuff Tear and Rotator Cuff Tendinitis, is active but no longer recruiting, sponsored by InGeneron.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 168 participants
- Enrollment target
- 14
- Study locations
Study Summary
The purpose of this investigation is to evaluate the safety and superior effectiveness in functional improvement in patients with partial-thickness rotator cuff tears (PTRCTs) after the administration of a single injection of adipose-derived regenerative cells (ADRCs) into the partial-thickness rotator cuff tear compared to the administration of a single corticosteroid injection into the associated subacromial space.
Conditions Studied
Interventions
- DRUG Corticosteroid
- DEVICE Adipose Derived Regenerative Cells
Study Locations (14)
Florida
- Sports and Orthopedic Center - Coral Springs
- Universal Axon Clinical Research - Doral
- Shrock Clinical Research - Fort Lauderdale
- Andrews Institute for Orthopaedics and Sports Medicine - Gulf Breeze
California
- Biosolutions Clinical Research Center - La Mesa
- Lotus Clinical Research, LLC - Pasadena
Texas
- HD Research - Houston
- Texas Plastic Surgery - San Antonio
Arizona
- Arizona Research Center - Phoenix
Georgia
- Georgia Institute for Clinical Research - Marietta
Louisiana
- Tulane University School of Medicine - New Orleans
Michigan
- University of Michigan - Ann Arbor
North Dakota
- Sanford Medical Center - Fargo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2019-05-13 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03752827
The ClinicalTrials.gov registry entry for NCT03752827 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 78-participant average among 11 other Rotator Cuff Tear trials with a reported enrollment target (115% higher). The listed sponsor is InGeneron, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Rotator Cuff Tear appearing as the primary indexed condition, and to 2 interventions - of which Corticosteroid is the first listed.
NCT03752827 reports 14 study locations spanning 9 distinct geographic areas - top geographies include Florida, California, Texas.
Frequently Asked Questions
What is clinical trial NCT03752827 about?
NCT03752827 is a clinical study titled "Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears". The purpose of this investigation is to evaluate the safety and superior effectiveness in functional improvement in patients with partial-thickness rotator cuff tears (PTRCTs) after the administration of a single injection of adipose-derived regenerative cells (ADRCs) into the partial-thickness rota...
What is the current status of trial NCT03752827?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 168 participants. The study started on 2019-05-13. Estimated completion is 2025-12.
What conditions does trial NCT03752827 study?
This clinical trial studies the following conditions: Rotator Cuff Tear, Rotator Cuff Tendinitis.
What interventions are being tested in trial NCT03752827?
The interventions under investigation include: Corticosteroid (DRUG), Adipose Derived Regenerative Cells (DEVICE).
Who is sponsoring clinical trial NCT03752827?
This trial is sponsored by InGeneron, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03752827 being conducted?
This trial has 14 study locations across Arizona, California, Florida, Georgia, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rotator Cuff Tear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
FiberLocker® System Augmentation of Rotator Cuff Repairs
RECRUITING · NA
-
Oxandrolone Rotator Cuff Trial
ACTIVE NOT RECRUITING · NA
-
Regenexx™ SD Versus Exercise Therapy for Rotator Cuff Tears
COMPLETED · NA
-
Vascular Changes of Rotator Cuff Repair Augmented With a Whole Blood Fibrin Clot
COMPLETED · NA
-
BioWick SureLock Clinical Outcomes Study
COMPLETED · NA
-
Stromal Vascular Fraction Cell Therapy to Improve the Repair of Rotator Cuff Tears
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.